Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole for Difficult to Treat Bipolar Depression
NCT00198198Phase 4Completed
- Sponsor
- Indiana University School of Medicine
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aripiprazole in bipolar disorder (BD), sponsored by Indiana University School of Medicine. Primary endpoint: Hamilton Depression Rating Scale at 8 weeks. Started Aug 2005; status: completed.
02
Drugs
aripiprazole
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00198198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00198198.